| 21/04/23 | 07:00:01 | 21 Apr 2023 | | FORM 8 (OPD) – Allergy Therapeutics plc | RNS |
| 20/04/23 | 17:29:19 | 20 Apr 2023 | | Project Zebra Rule 2.9 Announcement | RNS |
| 19/04/23 | 07:00:04 | 19 Apr 2023 | | Skin-prick testing completes in PROTECT Trial | RNS |
| 06/04/23 | 14:01:01 | 6 Apr 2023 | | £40.75 million Facility with Equity Financing | RNS |
| 06/04/23 | 14:00:01 | 6 Apr 2023 | | Trading and Business Update | RNS |
| 29/03/23 | 07:00:06 | 29 Mar 2023 | | Publication of Interim Results Delayed | RNS |
| 27/03/23 | 07:00:03 | 27 Mar 2023 | | Patients dosed in VLP Peanut PROTECT trial | RNS |
| 08/03/23 | 17:28:26 | 8 Mar 2023 | | Block Listing Interim Review | RNS |
| 03/03/23 | 07:00:06 | 3 Mar 2023 | | PDMR Dealing | RNS |
| 07/02/23 | 18:29:07 | 7 Feb 2023 | | Result of AGM | RNS |
| 20/01/23 | 07:00:03 | 20 Jan 2023 | | Half-Year Trading Update 2023 | RNS |
| 13/01/23 | 17:27:02 | 13 Jan 2023 | | NOTICE OF 2022 ANNUAL GENERAL MEETING | RNS |
| 29/12/22 | 11:05:31 | 29 Dec 2022 | | Second Price Monitoring Extn | RNS |
| 29/12/22 | 11:00:14 | 29 Dec 2022 | | Price Monitoring Extension | RNS |
| 29/12/22 | 09:05:24 | 29 Dec 2022 | | Second Price Monitoring Extn | RNS |
| 29/12/22 | 09:00:10 | 29 Dec 2022 | | Price Monitoring Extension | RNS |
| 29/12/22 | 07:00:06 | 29 Dec 2022 | | Annual Report and Accounts Delayed | RNS |
| 28/12/22 | 07:00:08 | 28 Dec 2022 | | Director Resignation | RNS |
| 08/12/22 | 07:00:04 | 8 Dec 2022 | | Key updates on Grass MATA MPL and VLP Peanut | RNS |
| 06/12/22 | 07:00:09 | 6 Dec 2022 | | Appointment of Non-Executive Directors | RNS |
| 21/11/22 | 07:00:08 | 21 Nov 2022 | | Appointment of Interim CFO | RNS |
| 28/10/22 | 07:00:06 | 28 Oct 2022 | | Allergy to resume UK manufacturing production | RNS |
| 19/10/22 | 15:39:23 | 19 Oct 2022 | | Holding(s) in Company | RNS |
| 17/10/22 | 13:27:34 | 17 Oct 2022 | | Allergy Therapeutics – Result of GM | RNS |
| 04/10/22 | 07:00:05 | 4 Oct 2022 | | UK manufacturing update | RNS |
| 29/09/22 | 12:00:02 | 29 Sept 2022 | | Allergy Therapeutics at Investor Meet Company | RNS |
| 29/09/22 | 07:00:18 | 29 Sept 2022 | | Subscription and Debt Financing | RNS |
| 29/09/22 | 07:00:12 | 29 Sept 2022 | | Unaudited Preliminary Results 2022 | RNS |
| 05/09/22 | 07:00:11 | 5 Sept 2022 | | Allergy Therapeutics at H.C. Wainwright Conference | RNS |
| 02/09/22 | 16:50:44 | 2 Sept 2022 | | Total Voting Rights | RNS |
| 02/08/22 | 12:58:33 | 2 Aug 2022 | | Block Listing Interim Review | RNS |
| 15/07/22 | 07:00:05 | 15 Jul 2022 | | Trading Update and Notice of Results | RNS |
| 01/07/22 | 07:00:11 | 1 Jul 2022 | | Allergy Therapeutics at EAACI Congress 2022 | RNS |
| 26/05/22 | 07:00:07 | 26 May 2022 | | Nick Wykeman to step down as CFO | RNS |
| 23/05/22 | 07:00:06 | 23 May 2022 | | Allergy Therapeutics at H.C. Wainwright Conference | RNS |
| 25/04/22 | 07:00:08 | 25 Apr 2022 | | Allergy Therapeutics shares data at WAO-BSACI | RNS |
| 08/03/22 | 07:00:08 | 8 Mar 2022 | | Allergy Therapeutics at Cowen Health Conference | RNS |
| 07/03/22 | 07:00:11 | 7 Mar 2022 | | Allergy Therapeutics at Investor Meet Company | RNS |
| 03/03/22 | 07:00:08 | 3 Mar 2022 | | Allergy Therapeutics plc – Interim Results | RNS |
| 01/03/22 | 07:00:11 | 1 Mar 2022 | | Allergy Therapeutics shares positive new data | RNS |
| 24/02/22 | 16:41:28 | 24 Feb 2022 | | Second Price Monitoring Extn | RNS |
| 24/02/22 | 16:36:10 | 24 Feb 2022 | | Price Monitoring Extension | RNS |
| 24/02/22 | 14:06:22 | 24 Feb 2022 | | Second Price Monitoring Extn | RNS |
| 24/02/22 | 14:01:28 | 24 Feb 2022 | | Price Monitoring Extension | RNS |
| 02/02/22 | 11:05:03 | 2 Feb 2022 | | Secures new revolving credit facility | RNS |
| 01/02/22 | 14:16:01 | 1 Feb 2022 | | Total Voting Rights | RNS |
| 26/01/22 | 07:00:05 | 26 Jan 2022 | | FDA clearance of IND application for VLP Peanut | RNS |
| 24/01/22 | 13:13:58 | 24 Jan 2022 | | Holding(s) in Company | RNS |
| 13/01/22 | 07:00:04 | 13 Jan 2022 | | Half Year Trading Update & Notice of Results | RNS |
| 05/01/22 | 08:47:29 | 5 Jan 2022 | | Total Voting Rights | RNS |
